The cellular and molecular bases of leptin and ghrelin resistance in obesity (original) (raw)

• Stewart, S. T., Cutler, D. M. & Rosen, A. B. Forecasting the effects of obesity and smoking on U.S. life expectancy. N. Engl. J. Med. 361, 2252–2260 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994).
  CAS PubMed Google Scholar
• Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763–770 (1998).
  CAS PubMed Google Scholar
• Frederich, R. C. et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311–1314 (1995).
  CAS PubMed Google Scholar
• Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295 (1996).
  CAS PubMed Google Scholar
• Havel, P. J. et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J. Clin. Endocrinol. Metab. 81, 4406–4413 (1996).
  CAS PubMed Google Scholar
• Vaisse, C. et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14, 95–97 (1996).
  CAS PubMed Google Scholar
• Schwartz, M. W., Seeley, R. J., Campfield, L. A., Burn, P. & Baskin, D. G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98, 1101–1106 (1996).
  CAS PubMed PubMed Central Google Scholar
• Cohen, P. et al. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 1113–1121 (2001).
  CAS PubMed PubMed Central Google Scholar
• Dhillon, H. et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191–203 (2006).
  CAS PubMed Google Scholar
• Balthasar, N. et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983–991 (2004).
  CAS PubMed Google Scholar
• Leinninger, G. M. et al. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metab. 14, 313–323 (2011).
  CAS PubMed PubMed Central Google Scholar
• Rezai-Zadeh, K. et al. Leptin receptor neurons in the dorsomedial hypothalamus are key regulators of energy expenditure and body weight, but not food intake. Mol. Metab. 3, 681–693 (2014).
  CAS PubMed PubMed Central Google Scholar
• Dodd, G. T. et al. The thermogenic effect of leptin is dependent on a distinct population of prolactin-releasing peptide neurons in the dorsomedial hypothalamus. Cell Metab. 20, 639–649 (2014).
  CAS PubMed PubMed Central Google Scholar
• Leal-Cerro, A. et al. Serum leptin levels in male marathon athletes before and after the marathon run. J. Clin. Endocrinol. Metab. 83, 2376–2379 (1998).
  CAS PubMed Google Scholar
• Maffei, M. et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155–1161 (1995).
  CAS PubMed Google Scholar
• Lago, R., Gomez, R., Lago, F., Gomez-Reino, J. & Gualillo, O. Leptin beyond body weight regulation — current concepts concerning its role in immune function and inflammation. Cell. Immunol. 252, 139–145 (2008).
  CAS PubMed Google Scholar
• Lam, Q. L. & Lu, L. Role of leptin in immunity. Cell. Mol. Immunol. 4, 1–13 (2007).
  CAS PubMed Google Scholar
• Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L. & Sivitz, W. I. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100, 270–278 (1997).
  CAS PubMed PubMed Central Google Scholar
• Rahmouni, K., Haynes, W. G. & Mark, A. L. Cardiovascular and sympathetic effects of leptin. Curr. Hypertens. Rep. 4, 119–125 (2002).
  PubMed Google Scholar
• Elias, C. F. & Purohit, D. Leptin signaling and circuits in puberty and fertility. Cell. Mol. Life Sci. 70, 841–862 (2013).
  CAS PubMed Google Scholar
• Chen, X. X. & Yang, T. Roles of leptin in bone metabolism and bone diseases. J. Bone Miner. Metab. 33, 474–485 (2015).
  CAS PubMed Google Scholar
• Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263–1271 (1995).
  CAS PubMed Google Scholar
• Tartaglia, L. A. The leptin receptor. J. Biol. Chem. 272, 6093–6096 (1997).
  CAS PubMed Google Scholar
• Chua, S. C. Jr et al. Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. Genomics 45, 264–270 (1997).
  CAS PubMed Google Scholar
• Bates, S. H. & Myers, M. G. Jr. The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol. Metab. 14, 447–452 (2003).
  CAS PubMed Google Scholar
• Scott, M. M. et al. Leptin targets in the mouse brain. J. Comp. Neurol. 514, 518–532 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ihle, J. N. & Kerr, I. M. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11, 69–74 (1995).
  CAS PubMed Google Scholar
• Taniguchi, T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268, 251–255 (1995).
  CAS PubMed Google Scholar
• Kloek, C. et al. Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem. 277, 41547–41555 (2002).
  CAS PubMed Google Scholar
• Devos, R. et al. Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding. J. Biol. Chem. 272, 18304–18310 (1997).
  CAS PubMed Google Scholar
• Couturier, C. & Jockers, R. Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J. Biol. Chem. 278, 26604–26611 (2003).
  CAS PubMed Google Scholar
• Allison, M. B. & Myers, M. G. Jr. 20 years of leptin: connecting leptin signaling to biological function. J. Endocrinol. 223, T25–T35 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hekerman, P. et al. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J. 272, 109–119 (2005).
  CAS PubMed Google Scholar
• Gong, Y. et al. The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J. Biol. Chem. 282, 31019–31027 (2007).
  CAS PubMed Google Scholar
• Bjorbak, C. et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649–40657 (2000).
  CAS PubMed Google Scholar
• Cota, D. et al. Hypothalamic mTOR signaling regulates food intake. Science 312, 927–930 (2006).
  CAS PubMed Google Scholar
• Harlan, S. M., Guo, D. F., Morgan, D. A., Fernandes-Santos, C. & Rahmouni, K. Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab. 17, 599–606 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ottaway, N. et al. Diet-induced obese mice retain endogenous leptin action. Cell Metab. 21, 877–882 (2015).
  CAS PubMed PubMed Central Google Scholar
• Rosenbaum, M., Murphy, E. M., Heymsfield, S. B., Matthews, D. E. & Leibel, R. L. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J. Clin. Endocrinol. Metab. 87, 2391–2394 (2002).
  CAS PubMed Google Scholar
• Mark, A. L., Correia, M. L., Rahmouni, K. & Haynes, W. G. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens. 20, 1245–1250 (2002).
  CAS PubMed Google Scholar
• Correia, M. L. et al. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51, 439–442 (2002).
  CAS PubMed Google Scholar
• Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L. & Haynes, W. G. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54, 2012–2018 (2005).
  CAS PubMed Google Scholar
• Simonds, S. E. et al. Leptin mediates the increase in blood pressure associated with obesity. Cell 159, 1404–1416 (2014).
  CAS PubMed PubMed Central Google Scholar
• Mark, A. L. Selective leptin resistance revisited. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R566–R581 (2013).
  CAS PubMed PubMed Central Google Scholar
• Sinha, M. K. et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J. Clin. Invest. 98, 1277–1282 (1996).
  CAS PubMed PubMed Central Google Scholar
• Magni, P. et al. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin. Endocrinol. 62, 189–196 (2005).
  CAS Google Scholar
• Houseknecht, K. L. et al. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45, 1638–1643 (1996).
  CAS PubMed Google Scholar
• Schwartz, M. W., Peskind, E., Raskind, M., Boyko, E. J. & Porte, D. Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat. Med. 2, 589–593 (1996).
  CAS PubMed Google Scholar
• Morgan, D. A., Thedens, D. R., Weiss, R. & Rahmouni, K. Mechanisms mediating renal sympathetic activation to leptin in obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1730–R1736 (2008).
  CAS PubMed PubMed Central Google Scholar
• Banks, W. A. & Farrell, C. L. Impaired transport of leptin across the blood–brain barrier in obesity is acquired and reversible. Am. J. Physiol. Endocrinol. Metab. 285, E10–E15 (2003).
  CAS PubMed Google Scholar
• Pan, W. et al. Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice. Endocrinology 149, 2798–2806 (2008).
  CAS PubMed PubMed Central Google Scholar
• Caro, J. F. et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348, 159–161 (1996).
  CAS PubMed Google Scholar
• Banks, W. A. Leptin transport across the blood–brain barrier: implications for the cause and treatment of obesity. Curr. Pharm. Des. 7, 125–133 (2001).
  CAS PubMed Google Scholar
• de Git, K. C. & Adan, R. A. Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation. Obes. Rev. 16, 207–224 (2015).
  CAS PubMed Google Scholar
• Koga, S. et al. Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression. Neurobiol. Dis. 71, 180–192 (2014).
  CAS PubMed Google Scholar
• Jayaram, B. et al. Astrocytic leptin-receptor knockout mice show partial rescue of leptin resistance in diet-induced obesity. J. Appl. Physiol. 114, 734–741 (2013).
  CAS PubMed PubMed Central Google Scholar
• Pierce, A. A. & Xu, A. W. De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance. J. Neurosci. 30, 723–730 (2010).
  CAS PubMed PubMed Central Google Scholar
• Balland, E. et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab. 19, 293–301 (2014).
  CAS PubMed PubMed Central Google Scholar
• Lee, D. A. et al. Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche. Nat. Neurosci. 15, 700–702 (2012).
  CAS PubMed PubMed Central Google Scholar
• Zhang, C. et al. Tat-modified leptin is more accessible to hypothalamus through brain–blood barrier with a significant inhibition of body-weight gain in high-fat-diet fed mice. Exp. Clin. Endocrinol. Diabetes 118, 31–37 (2010).
  CAS PubMed Google Scholar
• Guo, D. F. & Rahmouni, K. Molecular basis of the obesity associated with Bardet–Biedl syndrome. Trends Endocrinol. Metab. 22, 286–293 (2011).
  CAS PubMed PubMed Central Google Scholar
• Guo, D. F. et al. The BBsome controls energy homeostasis by mediating the transport of the leptin receptor to the plasma membrane. PLoS Genet. 12, e1005890 (2016).
  PubMed PubMed Central Google Scholar
• Seo, S. et al. Requirement of Bardet–Biedl syndrome proteins for leptin receptor signaling. Hum. Mol. Genet. 18, 1323–1331 (2009).
  CAS PubMed PubMed Central Google Scholar
• Irani, B. G., Dunn-Meynell, A. A. & Levin, B. E. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 148, 310–316 (2007).
  CAS PubMed Google Scholar
• Starr, R. et al. A family of cytokine-inducible inhibitors of signalling. Nature 387, 917–921 (1997).
  CAS PubMed Google Scholar
• Minamoto, S. et al. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 237, 79–83 (1997).
  CAS PubMed Google Scholar
• Bjorbaek, C., Elmquist, J. K., Frantz, J. D., Shoelson, S. E. & Flier, J. S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1, 619–625 (1998).
  CAS PubMed Google Scholar
• Howard, J. K. et al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10, 734–738 (2004).
  CAS PubMed Google Scholar
• Mori, H. et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10, 739–743 (2004).
  CAS PubMed Google Scholar
• Pedroso, J. A. et al. Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity. Mol. Metab. 3, 608–618 (2014).
  CAS PubMed PubMed Central Google Scholar
• Reed, A. S. et al. Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis. Diabetes 59, 894–906 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ahmad, F., Li, P. M., Meyerovitch, J. & Goldstein, B. J. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J. Biol. Chem. 270, 20503–20508 (1995).
  CAS PubMed Google Scholar
• Maegawa, H. et al. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J. Biol. Chem. 270, 7724–7730 (1995).
  CAS PubMed Google Scholar
• Seely, B. L. et al. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45, 1379–1385 (1996).
  CAS PubMed Google Scholar
• Myers, M. P. et al. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276, 47771–47774 (2001).
  CAS PubMed Google Scholar
• Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544–1548 (1999).
  CAS PubMed Google Scholar
• Cook, W. S. & Unger, R. H. Protein tyrosine phosphatase 1B: a potential leptin resistance factor of obesity. Dev. Cell 2, 385–387 (2002).
  CAS PubMed Google Scholar
• Zabolotny, J. M. et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2, 489–495 (2002).
  CAS PubMed Google Scholar
• Klaman, L. D. et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20, 5479–5489 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bence, K. K. et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 12, 917–924 (2006).
  CAS PubMed Google Scholar
• Tsou, R. C., Zimmer, D. J., De Jonghe, B. C. & Bence, K. K. Deficiency of PTP1B in leptin receptor-expressing neurons leads to decreased body weight and adiposity in mice. Endocrinology 153, 4227–4237 (2012).
  CAS PubMed PubMed Central Google Scholar
• Tsou, R. C., Rak, K. S., Zimmer, D. J. & Bence, K. K. Improved metabolic phenotype of hypothalamic PTP1B-deficiency is dependent upon the leptin receptor. Mol. Metab. 3, 301–312 (2014).
  CAS PubMed PubMed Central Google Scholar
• He, R. J., Yu, Z. H., Zhang, R. Y. & Zhang, Z. Y. Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol. Sin. 35, 1227–1246 (2014).
  CAS PubMed PubMed Central Google Scholar
• Lantz, K. A. et al. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obes. (Silver Spring) 18, 1516–1523 (2010).
  CAS Google Scholar
• Ahima, R. S. et al. Appetite suppression and weight reduction by a centrally active aminosterol. Diabetes 51, 2099–2104 (2002).
  CAS PubMed Google Scholar
• Takahashi, N., Qi, Y., Patel, H. R. & Ahima, R. S. A novel aminosterol reverses diabetes and fatty liver disease in obese mice. J. Hepatol. 41, 391–398 (2004).
  CAS PubMed Google Scholar
• Zasloff, M. et al. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties. Int. J. Obes. Relat. Metab. Disord. 25, 689–697 (2001).
  CAS PubMed Google Scholar
• Isis Pharmaceuticals, Inc. Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. PRNewswire www.prnewswire.com/news-releases/isis-pharmaceuticals-reports-positive-phase-2-data-for-isis-113715-in-patients-with-type-2-diabetes-65238987.html (2009).
• Loh, K. et al. Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab. 14, 684–699 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dodd, G. T. et al. Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell 160, 88–104 (2015).
  CAS PubMed PubMed Central Google Scholar
• Rousso-Noori, L. et al. Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner. Cell Metab. 13, 562–572 (2011).
  CAS PubMed Google Scholar
• Toledano-Katchalski, H. et al. Protein tyrosine phosphatase ε inhibits signaling by mitogen-activated protein kinases. Mol. Cancer Res. 1, 541–550 (2003).
  CAS PubMed Google Scholar
• Schmidt, M., Dekker, F. J. & Maarsingh, H. Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol. Rev. 65, 670–709 (2013).
  PubMed Google Scholar
• McKnight, G. S. et al. Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog. Horm. Res. 53, 139–159 (1998).
  CAS PubMed Google Scholar
• Almahariq, M., Mei, F. C. & Cheng, X. Cyclic AMP sensor EPAC proteins and energy homeostasis. Trends Endocrinol. Metab. 25, 60–71 (2014).
  CAS PubMed Google Scholar
• Fukuda, M., Williams, K. W., Gautron, L. & Elmquist, J. K. Induction of leptin resistance by activation of cAMP–Epac signaling. Cell Metab. 13, 331–339 (2011).
  CAS PubMed PubMed Central Google Scholar
• Yan, J. et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol. Cell. Biol. 33, 918–926 (2013).
  CAS PubMed PubMed Central Google Scholar
• De Souza, C. T. et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199 (2005).
  CAS PubMed Google Scholar
• Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012).
  CAS PubMed Google Scholar
• Posey, K. A. et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 296, E1003–E1012 (2009).
  CAS PubMed Google Scholar
• Zhang, X. et al. Hypothalamic IKKß/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61–73 (2008).
  CAS PubMed PubMed Central Google Scholar
• Romanatto, T. et al. Deletion of tumor necrosis factor-α receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J. Biol. Chem. 284, 36213–36222 (2009).
  CAS PubMed PubMed Central Google Scholar
• Milanski, M. et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61, 1455–1462 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ozcan, L. et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9, 35–51 (2009).
  CAS PubMed Google Scholar
• Hosoi, T. et al. Endoplasmic reticulum stress induces leptin resistance. Mol. Pharmacol. 74, 1610–1619 (2008).
  CAS PubMed Google Scholar
• Liu, J., Lee, J., Salazar Hernandez, M. A., Mazitschek, R. & Ozcan, U. Treatment of obesity with celastrol. Cell 161, 999–1011 (2015).
  CAS PubMed PubMed Central Google Scholar
• Williams, K. W. et al. Xbp1s in Pomc neurons connects ER stress with energy balance and glucose homeostasis. Cell Metab. 20, 471–482 (2014).
  CAS PubMed PubMed Central Google Scholar
• Perlmutter, D. H. Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr. Res. 52, 832–836 (2002).
  PubMed Google Scholar
• Carducci, M. A. et al. A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin. Cancer Res. 7, 3047–3055 (2001).
  CAS PubMed Google Scholar
• Ma, X. et al. Celastrol protects against obesity and metabolic dysfunction through activation of a HSF1–PGC1α transcriptional axis. Cell Metab. 22, 695–708 (2015).
  CAS PubMed Google Scholar
• Contreras, C. et al. Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance. Cell Rep. 9, 366–377 (2014).
  CAS PubMed PubMed Central Google Scholar
• Contreras, C. et al. Effects of neonatal programming on hypothalamic mechanisms controlling energy balance. Horm. Metab. Res. 45, 935–944 (2013).
  CAS PubMed Google Scholar
• Duque-Guimaraes, D. E. & Ozanne, S. E. Nutritional programming of insulin resistance: causes and consequences. Trends Endocrinol. Metab. 24, 525–535 (2013).
  CAS PubMed Google Scholar
• Lopez, M. et al. A possible role of neuropeptide Y, agouti-related protein and leptin receptor isoforms in hypothalamic programming by perinatal feeding in the rat. Diabetologia 48, 140–148 (2005).
  CAS PubMed Google Scholar
• Lopez, M. et al. Perinatal overfeeding in rats results in increased levels of plasma leptin but unchanged cerebrospinal leptin in adulthood. Int. J. Obes. 31, 371–377 (2007).
  CAS Google Scholar
• Lucas, A. Programming by early nutrition: an experimental approach. J. Nutr. 128, 401S–406S (1998).
  CAS PubMed Google Scholar
• Morris, M. J., Velkoska, E. & Cole, T. J. Central and peripheral contributions to obesity-associated hypertension: impact of early overnourishment. Exp. Physiol. 90, 697–702 (2005).
  PubMed Google Scholar
• Davidowa, H. & Plagemann, A. Different responses of ventromedial hypothalamic neurons to leptin in normal and early postnatally overfed rats. Neurosci. Lett. 293, 21–24 (2000).
  CAS PubMed Google Scholar
• Davidowa, H. & Plagemann, A. Decreased inhibition by leptin of hypothalamic arcuate neurons in neonatally overfed young rats. Neuroreport 11, 2795–2798 (2000).
  CAS PubMed Google Scholar
• Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).
  CAS PubMed Google Scholar
• Tschop, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000).
  CAS PubMed Google Scholar
• Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001).
  CAS PubMed Google Scholar
• Muller, T. D. et al. Ghrelin. Mol. Metab. 4, 437–460 (2015).
  CAS PubMed PubMed Central Google Scholar
• Seoane, L. M. et al. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur. J. Endocrinol. 143, R7–R9 (2000).
  CAS PubMed Google Scholar
• Peino, R. et al. Ghrelin-induced growth hormone secretion in humans. Eur. J. Endocrinol. 143, R11–R14 (2000).
  CAS PubMed Google Scholar
• Takaya, K. et al. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 85, 4908–4911 (2000).
  CAS PubMed Google Scholar
• Wren, A. M. et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992 (2001).
  CAS PubMed Google Scholar
• Theander-Carrillo, C. et al. Ghrelin action in the brain controls adipocyte metabolism. J. Clin. Invest. 116, 1983–1993 (2006).
  CAS PubMed PubMed Central Google Scholar
• López, M. et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 7, 389–399 (2008).
  PubMed Google Scholar
• Foster-Schubert, K. E. & Cummings, D. E. Emerging therapeutic strategies for obesity. Endocr. Rev. 27, 779–793 (2006).
  PubMed Google Scholar
• Zorrilla, E. P. et al. Vaccination against weight gain. Proc. Natl Acad. Sci. USA 103, 13226–13231 (2006).
  CAS PubMed PubMed Central Google Scholar
• Muller, T. D., Perez-Tilve, D., Tong, J., Pfluger, P. T. & Tschop, M. H. Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia. J. Cachexia Sarcopenia Muscle 1, 159–167 (2010).
  PubMed PubMed Central Google Scholar
• Lainscak, M., von Haehling, S., Doehner, W. & Anker, S. D. The obesity paradox in chronic disease: facts and numbers. J. Cachexia Sarcopenia Muscle 3, 1–4 (2012).
  PubMed PubMed Central Google Scholar
• von Haehling, S., Morley, J. E. & Anker, S. D. From muscle wasting to sarcopenia and myopenia: update 2012. J. Cachexia Sarcopenia Muscle 3, 213–217 (2012).
  PubMed PubMed Central Google Scholar
• Gutierrez, J. A. et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl Acad. Sci. USA 105, 6320–6325 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yang, J., Brown, M. S., Liang, G., Grishin, N. V. & Goldstein, J. L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387–396 (2008).
  CAS PubMed Google Scholar
• Gonzalez, C. R., Vazquez, M. J., López, M. & Dieguez, C. Influence of chronic undernutrition and leptin on GOAT mRNA levels in rat stomach mucosa. J. Mol. Endocrinol. 41, 415–421 (2008).
  CAS PubMed Google Scholar
• Kirchner, H. et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med. 15, 741–745 (2009).
  CAS PubMed PubMed Central Google Scholar
• Delhanty, P. J., Neggers, S. J. & van der Lely, A. J. Mechanisms in endocrinology: ghrelin: the differences between acyl- and des-acyl ghrelin. Eur. J. Endocrinol. 167, 601–608 (2012).
  CAS PubMed Google Scholar
• Delhanty, P. J., Neggers, S. J. & van der Lely, A. J. Should we consider des-acyl ghrelin as a separate hormone and if so, what does it do? Front. Horm. Res. 42, 163–174 (2014).
  PubMed Google Scholar
• Toshinai, K. et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147, 2306–2314 (2006).
  CAS PubMed Google Scholar
• Heppner, K. M. et al. Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors. Diabetes 63, 122–131 (2014).
  CAS PubMed Google Scholar
• Zhang, J. V. et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310, 996–999 (2005).
  CAS PubMed Google Scholar
• Seoane, L. M., Al Massadi, O., Pazos, Y., Pagotto, U. & Casanueva, F. F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J. Endocrinol. Invest. 29, RC13–RC15 (2006).
  CAS PubMed Google Scholar
• Nogueiras, R. et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148, 21–26 (2007).
  CAS PubMed Google Scholar
• Gourcerol, G., St Pierre, D. H. & Tache, Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul. Pept. 141, 1–7 (2007).
  CAS PubMed Google Scholar
• Kobelt, P. et al. Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides 29, 1018–1027 (2008).
  CAS PubMed PubMed Central Google Scholar
• Tschop, M. et al. Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24, RC19–RC21 (2001).
  CAS PubMed Google Scholar
• Cummings, D. E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714–1719 (2001).
  CAS PubMed Google Scholar
• Drazen, D. L., Vahl, T. P., D'Alessio, D. A., Seeley, R. J. & Woods, S. C. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 147, 23–30 (2006).
  CAS PubMed Google Scholar
• Seoane, L. M. et al. Sensory stimuli directly acting at the central nervous system regulate gastric ghrelin secretion. an ex vivo organ culture study. Endocrinology 148, 3998–4006 (2007).
  CAS PubMed Google Scholar
• Briggs, D. I. & Andrews, Z. B. Metabolic status regulates ghrelin function on energy homeostasis. Neuroendocrinology 93, 48–57 (2011).
  CAS PubMed Google Scholar
• Zigman, J. M., Bouret, S. G. & Andrews, Z. B. Obesity impairs the action of the neuroendocrine ghrelin system. Trends Endocrinol. Metab. 27, 54–63 (2016).
  CAS PubMed Google Scholar
• Tschop, M. et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707–709 (2001).
  CAS PubMed Google Scholar
• Otto, B. et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145, 669–673 (2001).
  CAS PubMed Google Scholar
• Otto, B. et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 30, 577–581 (2005).
  CAS PubMed Google Scholar
• Cummings, D. E. et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med. 8, 643–644 (2002).
  CAS PubMed Google Scholar
• DelParigi, A. et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader–Willi syndrome. J. Clin. Endocrinol. Metab. 87, 5461–5464 (2002).
  CAS PubMed Google Scholar
• Feigerlová, E. et al. Hyperghrelinemia precedes obesity in Prader–Willi syndrome. J. Clin. Endocrinol. Metab. 93, 2800–2805 (2008).
  PubMed Google Scholar
• Kweh, F. A. et al. Hyperghrelinemia in Prader–Willi syndrome begins in early infancy long before the onset of hyperphagia. Am. J. Med. Genet. A. 167A, 69–79 (2015).
  Google Scholar
• De Waele, K. et al. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader–Willi syndrome. Eur. J. Endocrinol. 159, 381–388 (2008).
  CAS PubMed Google Scholar
• Neary, N. M. et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 2832–2836 (2004).
  CAS PubMed Google Scholar
• Schmid, D. A. et al. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 30, 1187–1192 (2005).
  CAS PubMed Google Scholar
• Druce, M. R. et al. Ghrelin increases food intake in obese as well as lean subjects. Int. J. Obes. Relat. Metab. Disord. 29, 1130–1136 (2005).
  CAS Google Scholar
• Druce, M. R. et al. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int. J. Obes. 30, 293–296 (2005).
  Google Scholar
• Liu, J. et al. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J. Clin. Endocrinol. Metab. 93, 1980–1987 (2008).
  CAS PubMed PubMed Central Google Scholar
• Sun, Y., Ahmed, S. & Smith, R. G. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23, 7973–7981 (2003).
  CAS PubMed PubMed Central Google Scholar
• Pfluger, P. T. et al. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G610–G618 (2008).
  CAS PubMed Google Scholar
• McFarlane, M. R., Brown, M. S., Goldstein, J. L. & Zhao, T. J. Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet. Cell Metab. 20, 54–60 (2014).
  CAS PubMed PubMed Central Google Scholar
• Nishi, Y. et al. Ingested medium-chain fatty acids are directly utilized for the acyl-modification of ghrelin. Endocrinology 146, 2255–2264 (2005).
  CAS PubMed Google Scholar
• Sangiao-Alvarellos, S. et al. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology 150, 4562–4574 (2009).
  CAS PubMed PubMed Central Google Scholar
• Perez-Tilve, D. et al. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J. 25, 2814–2822 (2011).
  CAS PubMed PubMed Central Google Scholar
• Andrews, Z. B. et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454, 846–851 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gao, S., Casals, N., Keung, W., Moran, T. H. & Lopaschuk, G. D. Differential effects of central ghrelin on fatty acid metabolism in hypothalamic ventral medial and arcuate nuclei. Physiol. Behav. 118, 165–170 (2013).
  CAS PubMed Google Scholar
• Al, M. O. et al. Review of novel aspects of the regulation of ghrelin secretion. Curr. Drug Metab. 15, 398–413 (2014).
  Google Scholar
• Sun, Y., Wang, P., Zheng, H. & Smith, R. G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl Acad. Sci. USA 101, 4679–4684 (2004).
  CAS PubMed PubMed Central Google Scholar
• Guan, X. M. et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48, 23–29 (1997).
  CAS PubMed Google Scholar
• Tannenbaum, G. S., Lapointe, M., Beaudet, A. & Howard, A. D. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139, 4420–4423 (1998).
  CAS PubMed Google Scholar
• Willesen, M. G., Kristensen, P. & Romer, J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70, 306–316 (1999).
  CAS PubMed Google Scholar
• Nogueiras, R. et al. Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53, 2552–2558 (2004).
  CAS PubMed Google Scholar
• Garcia, A., Alvarez, C. V., Smith, R. G. & Dieguez, C. Regulation of pit-1 expression by ghrelin and ghrp-6 through the gh secretagogue receptor. Mol. Endocrinol. 15, 1484–1495 (2001).
  CAS PubMed Google Scholar
• van der Lely, A. J., Tschop, M., Heiman, M. L. & Ghigo, E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25, 426–457 (2004).
  CAS PubMed Google Scholar
• Anderson, K. A. et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 7, 377–388 (2008).
  CAS PubMed Google Scholar
• Lage, R. et al. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J. 24, 2670–2679 (2010).
  CAS PubMed PubMed Central Google Scholar
• Varela, L. et al. Ghrelin and lipid metabolism: key partners in energy balance. J. Mol. Endocrinol. 46, R43–R63 (2011).
  CAS PubMed Google Scholar
• López, M., Nogueiras, R., Tena-Sempere, M. & Dieguez, C. Hypothalamic AMPK: a canonical regulator of whole-body energy balance. Nat. Rev. Endocrinol. 12, 421–432 (2016).
  PubMed Google Scholar
• Dietrich, M. O. et al. Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. J. Neurosci. 30, 11815–11825 (2010).
  CAS PubMed PubMed Central Google Scholar
• Velasquez, D. A. et al. The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes 60, 1177–1185 (2011).
  CAS PubMed PubMed Central Google Scholar
• Andersson, U. et al. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279, 12005–12008 (2004).
  CAS PubMed Google Scholar
• Kola, B. et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3, e1797 (2008).
  PubMed PubMed Central Google Scholar
• Sangiao-Alvarellos, S. et al. Influence of ghrelin and GH deficiency on AMPK and hypothalamic lipid metabolism. J. Neuroendocrinol. 22, 543–556 (2010).
  CAS PubMed Google Scholar
• Yavari, A. et al. Chronic activation of γ2 AMPK induces obesity and reduces ß cell function. Cell Metab. 23, 821–836 (2016).
  CAS PubMed PubMed Central Google Scholar
• Sierra, A. Y. et al. CPT1C is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity. J. Biol. Chem. 283, 6878–6885 (2008).
  CAS PubMed Google Scholar
• Ramírez, S. et al. Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes 62, 2329–2337 (2013).
  PubMed PubMed Central Google Scholar
• Martins, L. et al. Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin. PLoS ONE 7, e46923 (2012).
  CAS PubMed PubMed Central Google Scholar
• Stevanovic, D. et al. Ghrelin-induced food intake and adiposity depend on central mTORC1/S6K1 signaling. Mol. Cell. Endocrinol. 381, 280–290 (2013).
  CAS PubMed Google Scholar
• Martinez de Morentin, P. B. et al. Hypothalamic mTOR: the rookie energy sensor. Curr. Mol. Med. 14, 3–21 (2014).
  CAS PubMed Google Scholar
• Sakkou, M. et al. A role for brain-specific homeobox factor Bsx in the control of hyperphagia and locomotory behavior. Cell Metab. 5, 450–463 (2007).
  CAS PubMed Google Scholar
• Seoane, L. M. et al. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144, 544–551 (2003).
  CAS PubMed Google Scholar
• Nogueiras, R. et al. Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology 149, 3009–3015 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yang, Y., Atasoy, D., Su, H. H. & Sternson, S. M. Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop. Cell 146, 992–1003 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kohno, D., Gao, H. Z., Muroya, S., Kikuyama, S. & Yada, T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52, 948–956 (2003).
  CAS PubMed Google Scholar
• Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649–661 (2003).
  CAS PubMed Google Scholar
• Romero-Pico, A. et al. Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin. Neuropsychopharmacology 38, 1296–1307 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kola, B. et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 280, 25196–25201 (2005).
  CAS PubMed Google Scholar
• Lim, C. T. et al. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism. Mol. Cell. Endocrinol. 365, 303–308 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kola, B. et al. The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release. FASEB J. 27, 5112–5121 (2013).
  CAS PubMed PubMed Central Google Scholar
• Olszewski, P. K., Grace, M. K., Billington, C. J. & Levine, A. S. Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides 24, 919–923 (2003).
  CAS PubMed Google Scholar
• Olszewski, P. K., Billington, C. J., Grace, M. K. & Levine, A. S. α-Melanocyte stimulating hormone and ghrelin: central interaction in feeding control. Peptides 28, 2084–2089 (2007).
  CAS PubMed Google Scholar
• Abizaid, A. et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116, 3229–3239 (2006).
  CAS PubMed PubMed Central Google Scholar
• Romero-Pico, A. et al. Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelin. Psychopharmacology 229, 275–283 (2013).
  CAS PubMed Google Scholar
• Hewson, A. K., Tung, L. Y., Connell, D. W., Tookman, L. & Dickson, S. L. The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic. Diabetes 51, 3412–3419 (2002).
  CAS PubMed Google Scholar
• Kohno, D. et al. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 148, 2251–2263 (2007).
  CAS PubMed Google Scholar
• Scott, V., McDade, D. M. & Luckman, S. M. Rapid changes in the sensitivity of arcuate nucleus neurons to central ghrelin in relation to feeding status. Physiol. Behav. 90, 180–185 (2007).
  CAS PubMed Google Scholar
• Briggs, D. I. et al. Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner. Endocrinology 154, 709–717 (2013).
  CAS PubMed Google Scholar
• Perreault, M. et al. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int. J. Obes. Relat. Metab. Disord. 28, 879–885 (2004).
  CAS PubMed Google Scholar
• English, P. J., Ghatei, M. A., Malik, I. A., Bloom, S. R. & Wilding, J. P. Food fails to suppress ghrelin levels in obese humans. J. Clin. Endocrinol. Metab. 87, 2984 (2002).
  CAS PubMed Google Scholar
• Uchida, A. et al. Altered ghrelin secretion in mice in response to diet-induced obesity and Roux-en-Y gastric bypass. Mol. Metab. 3, 717–730 (2014).
  CAS PubMed PubMed Central Google Scholar
• Mani, B. K., Osborne-Lawrence, S., Vijayaraghavan, P., Hepler, C. & Zigman, J. M. β1-adrenergic receptor deficiency in ghrelin-expressing cells causes hypoglycemia in susceptible individuals. J. Clin. Invest. 126, 3467–3478 (2016).
  PubMed PubMed Central Google Scholar
• Banks, W. A., Burney, B. O. & Robinson, S. M. Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood–brain barrier. Peptides 29, 2061–2065 (2008).
  CAS PubMed PubMed Central Google Scholar
• Briggs, D. I., Enriori, P. J., Lemus, M. B., Cowley, M. A. & Andrews, Z. B. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 151, 4745–4755 (2010).
  CAS PubMed Google Scholar
• Gardiner, J. V. et al. The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. Gastroenterology 138, 2468–2476 (2010).
  CAS PubMed Google Scholar
• Briggs, D. I. et al. Evidence that diet-induced hyperleptinemia, but not hypothalamic gliosis, causes ghrelin resistance in NPY/AgRP neurons of male mice. Endocrinology 155, 2411–2422 (2014).
  PubMed Google Scholar
• Steculorum, S. M. et al. Neonatal ghrelin programs development of hypothalamic feeding circuits. J. Clin. Invest. 125, 846–858 (2015).
  PubMed PubMed Central Google Scholar
• Collden, G. et al. Neonatal overnutrition causes early alterations in the central response to peripheral ghrelin. Mol. Metab. 4, 15–24 (2014).
  PubMed PubMed Central Google Scholar
• Coll, A. P., Farooqi, I. S. & O'Rahilly, S. The hormonal control of food intake. Cell 129, 251–262 (2007).
  CAS PubMed PubMed Central Google Scholar
• Williams, K. W. & Elmquist, J. K. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat. Neurosci. 15, 1350–1355 (2012).
  CAS PubMed PubMed Central Google Scholar
• Perello, M. et al. Functional implications of limited leptin receptor and ghrelin receptor coexpression in the brain. J. Comp. Neurol. 520, 281–294 (2012).
  CAS PubMed PubMed Central Google Scholar
• Stephens, T. W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530–532 (1995).
  CAS PubMed Google Scholar
• Hahn, T. M., Breininger, J. F., Baskin, D. G. & Schwartz, M. W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1, 271–272 (1998).
  CAS PubMed Google Scholar
• Elias, C. F. et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23, 775–786 (1999).
  CAS PubMed Google Scholar
• de Morentin, P. B. & López, M. “Mens sana in corpore sano”: exercise and hypothalamic ER stress. PLoS Biol. 8, e1000464 (2010).
  Google Scholar
• Naznin, F. et al. Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation. J. Endocrinol. 226, 81–92 (2015).
  CAS PubMed PubMed Central Google Scholar
• Martin, T. L. et al. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 281, 18933–18941 (2006).
  CAS PubMed Google Scholar
• Dagon, Y. et al. p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab. 16, 104–112 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lockie, S. H., Dinan, T., Lawrence, A. J., Spencer, S. J. & Andrews, Z. B. Diet-induced obesity causes ghrelin resistance in reward processing tasks. Psychoneuroendocrinology 62, 114–120 (2015).
  CAS PubMed Google Scholar
• Finger, B. C., Dinan, T. G. & Cryan, J. F. Diet-induced obesity blunts the behavioural effects of ghrelin: studies in a mouse-progressive ratio task. Psychopharmacology 220, 173–181 (2012).
  CAS PubMed Google Scholar
• Wang, W. & Tao, Y. X. Ghrelin receptor mutations and human obesity. Prog. Mol. Biol. Transl Sci. 140, 131–150 (2016).
  CAS PubMed Google Scholar
• Pantel, J. et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest. 116, 760–768 (2006).
  CAS PubMed PubMed Central Google Scholar
• Pantel, J. et al. Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J. Clin. Endocrinol. Metab. 94, 4334–4341 (2009).
  CAS PubMed Google Scholar
• Liu, G., Fortin, J. P., Beinborn, M. & Kopin, A. S. Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. J. Pharmacol. Exp. Ther. 322, 1036–1043 (2007).
  CAS PubMed Google Scholar
• Inoue, H. et al. Identification and functional analysis of novel human growth hormone secretagogue receptor (GHSR) gene mutations in Japanese subjects with short stature. J. Clin. Endocrinol. Metab. 96, E373–E378 (2011).
  CAS PubMed Google Scholar
• Rahmouni, K. Obesity-associated hypertension: recent progress in deciphering the pathogenesis. Hypertension 64, 215–221 (2014).
  CAS PubMed Google Scholar